Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab. [electronic resource]
Producer: 20061221Description: 1830-40 p. digitalISSN:- 1042-8194
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Follicular -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Prospective Studies
- Rituximab
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.